搜索临床试验以:initiate
总计304个结果
-
Pomeranian Medical University Szczecin尚未招聘
-
University of Alabama at Birmingham招聘中
-
Nagoya UniversityJapan Agency for Medical Research and Development招聘中
-
Gangnam Severance Hospital招聘中
-
University of Erlangen-Nürnberg招聘中
-
Otsuka Canada Pharmaceutical Inc.Lundbeck Canada Inc.招聘中
-
Biogen招聘中与 SOD1 基因突变相关的肌萎缩侧索硬化症美国, 加拿大, 西班牙, 澳大利亚, 德国, 意大利, 日本, 大韩民国, 英国, 比利时, 巴西, 法国, 波兰, 瑞典
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Osaka UniversityJapan Agency for Medical Research and Development招聘中
-
The Royal Wolverhampton Hospitals NHS TrustGebauer Company招聘中
-
University of California, DavisYale University; University of Utah尚未招聘阿片类药物使用障碍
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Kansas City Heart Rhythm Research FoundationTexas Cardiac Arrhythmia Research Foundation; Munson Medical Center招聘中
-
Yale UniversityHarvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA); University of... 和其他合作者招聘中
-
Asian Institute of Gastroenterology, India招聘中
-
Second Xiangya Hospital of Central South University尚未招聘
-
Hull University Teaching Hospitals NHS TrustUniversity of Hull招聘中
-
Oslo University HospitalVestre Viken Hospital Trust; University Hospital of North Norway; Diakonhjemmet Hospital; Ostfold... 和其他合作者招聘中
-
China National Center for Cardiovascular Diseases招聘中
-
Dr. Damon ScalesCanadian Institutes of Health Research (CIHR); Sunnybrook Research Institute招聘中
-
National Hospital Organization Osaka National HospitalNetwork for Clinical Stroke Trials; The BMS/Pfizer Japan Thrombosis Investigator Initiated Research...招聘中
-
University of AarhusHorsens Hospital; Regionshospitalet Silkeborg邀请报名
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH)完全的
-
Green Cross WellbeingChung-Ang University Hosptial, Chung-Ang University College of Medicine完全的
-
Novartis Pharmaceuticals暂时不可用
-
Novartis Pharmaceuticals可用的急性髓性白血病 | 肥大细胞白血病 | 侵袭性系统性肥大细胞增多症 | 系统性肥大细胞增多症伴有血液肿瘤 | FMS 样酪氨酸激酶 3 (FLT3)-突变的急性髓性白血病
-
Karolinska InstitutetLantmännen完全的
-
Weill Medical College of Cornell UniversityJazz Pharmaceuticals完全的
-
Centre Hospitalier Universitaire Dijon完全的
-
Novartis Pharmaceuticals可用的原发性骨髓纤维化 (PMF) | 真性红细胞增多症 (PV) | 红细胞增多症后骨髓纤维化 (PPV MF) | 血小板增多症骨髓纤维化 (PET-MF) | 严重/非常严重的 COVID-19 疾病 | 类固醇难治性急性移植物抗宿主病(SR aGVHD) | 类固醇难治性慢性移植物抗宿主病 (SR cGVHD)
-
Novartis Pharmaceuticals可用的非小细胞肺癌 | 非小细胞肺癌 | 癌,非小细胞肺癌 | 非小细胞肺癌
-
Novartis Pharmaceuticals可用的PIK3CA 相关过度生长谱 (PROS)